Last reviewed · How we verify

NCT04629859

Orthognathic Surgeries and Pharyngeal Airway Space

Completed NA Last updated 7 August 2023
What this trial tests

NA trial testing mandibular setback and maxillary advancement in Mandibular Prognathism in 24 participants. Completed in 1 December 2020.

Timeline
1 January 2020
Primary endpoint
30 November 2020
1 December 2020

Quick facts

Lead sponsorFayoum University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment24
Start date1 January 2020
Primary completion30 November 2020
Estimated completion1 December 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Fayoum University

Who can join

18 and older, any sex, with Mandibular Prognathism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

twenty-four patients with dentoskeletal deformity of class III will be divided equally into two groups and will be subjected to orthognathic surgeries group A; will be treated by mandibular setback surgery while group B will be treated with bimaxillary orthognathic surgery in the form of mandibular setback and maxillary advancement surgeries. the total pharyngeal airway will be measured on lateral cephalometric radiographs, integrating retro-palatal and retro-glossal area, and statistically will be compared preoperative, immediate postoperative, and at 6 months post-surgically

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Fayoum University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04629859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing